New sedation drug ciprofol tested against propofol for safer anesthesia in seniors
NCT ID NCT07670923
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares ciprofol and propofol, two drugs used to sedate elderly patients (ages 65-80) during short medical procedures without a breathing tube. Researchers will monitor heart rate, blood pressure, and breathing for 5 minutes after giving the drug. The goal is to see which drug causes fewer side effects on the heart and lungs. 108 participants will be enrolled at a single hospital in China.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ciprofol and propofol
- What this could lead to
- If ciprofol proves safer for heart and lung function, it could become a preferred sedation option for elderly patients undergoing short procedures.
- What could go wrong
- This is a small, early-phase trial (108 participants) comparing two drugs, so results may not apply broadly. Both drugs carry risks like low blood pressure or breathing problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMPARISON OF HEMODYNAMICS AND RESPIRATORY FUNCTION BETWEEN CIPROFOL AND PROPOFOL IN ELDERLY PATIENTS UNDERGOING NON-INTUBATED GENERAL ANESTHESIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cardiovascular and Cerebrovascular Disease Hospital, General Hospital of Ningxia Medical University
Yinchuan, Ningxia, 750000, China